U.S. Markets close in 18 mins

Viking Therapeutics Breaks Out After Gilead's Clinical Failure

Viking Therapeutics Breaks Out After Gilead's Clinical Failure

Viking Therapeutics shares moved higher after an analyst suggested that it could become a takeover target for Gilead following a clinical failure.